215 filings
Page 2 of 11
8-K
bfqm 7prcu
8 Jun 23
Departure of Directors or Certain Officers
4:12pm
8-K
1p977
6 Jun 23
Regulation FD Disclosure
3:45pm
8-K
sunvx2e71ne3q3cvcx
6 Jun 23
Regulation FD Disclosure
12:18pm
8-K
5tp18n1aaz hie
6 Jun 23
Regulation FD Disclosure
8:00am
8-K
uijn9l63hpoyu
4 May 23
Novocure Reports First Quarter 2023 Financial Results
7:02am
8-K
2qxl295 zs7ad5pqr4
26 Apr 23
Regulation FD Disclosure
10:03am
DEFA14A
qi3lxc 3l0a9
24 Apr 23
Additional proxy soliciting materials
7:08am
8-K
tqzm144loscvu4dw6
29 Mar 23
Kristin Stafford Joins Novocure Board of Directors
7:31am
S-8
39ne23cpqvh
23 Feb 23
Registration of securities for employees
7:07am
8-K
1frn55t 8j49wi37
23 Feb 23
Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
7:04am
8-K
zjmj114
9 Jan 23
Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update
7:02am
8-K
5kffympa6jeymyvy skg
5 Jan 23
Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
7:03am
8-K
60txlk5y6eo4m m9j
4 Nov 22
Other Events
8:35am
8-K
lv7nv
27 Oct 22
Novocure Reports Third Quarter 2022 Financial Results
7:20am
8-K
fm6jj84hadbcou6
28 Jul 22
Novocure Reports Second Quarter 2022 Financial Results
7:03am